Jorveza (Budesonide Orodispersible Tablet) is a prescription medication used to treat adults with eosinophilic oesophagitis, an inflammation of the oesophagus. This causes symptoms including dysphagia and obstruction of the oesophagus. Budesonide is a corticosteroid medication that works by reducing inflammation by attaching to immune cell receptors and reducing the release of substances that are involved in the inflammation process. Jorveza Orodispersible tablet dissolves in the mouth and carried by the saliva to the oesophagus where it reduces the inflammation and relieves the symptoms of eosinophilic oesophagitis.
We currently have the brand Jorveza from Canada manufactured by Avir Pharma in the strength of 1 mg tablets. The generic version is not available.
Seek emergency medical attention if you have any signs of a serious allergic reaction. Contact your doctor right away if you have any side effects that are severe. The common side effects of Jorveza may include:
• Decrease in the hormone cortisol in your blood;
• Fungal infections in the mouth and throat;
• Tingling or numbness in your mouth
You should not take Jorveza if you are allergic to Budesonide or if you have active tuberculosis, or an uncontrolled infection. Before you start taking this medication, tell your doctor about your medical history especially if you have diabetes, hypertension, osteoporosis, tuberculosis, peptic ulcer, cataract, or a family history of diabetes or glaucoma. Tell your doctor about all the medications you take including prescription, OTC, herbal products, and vitamins. There may be a drug interaction between Budesonide and other medications. Consult your doctor if you are pregnant or breastfeeding. Jorveza should not be used in children and adolescents under the age of 18 years old. Do not eat, drink, brush your teeth or rinse your mouth for at least 30 minutes after you take the Jorveza orodispersible tablet. Do not use any oral solutions, sprays, or chewable tablets for at least 30 minutes before or after taking Jorveza.
Check out our latest Blog Post
Canada's New International Travel Restrictions Complicate Access to Prescription Medications